Logo 1934 (Brexin L.A. 8 mg / 120 mg)
Generic Name: chlorpheniramine/pseudoephedrine
Pill imprint Logo 1934 has been identified as Brexin L.A. 8 mg / 120 mg.
Brexin LA is used in the treatment of allergic rhinitis; sinusitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Brexin LA 8 mg / 120 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo 1934
- 8 mg / 120 mg
- Red / Clear
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Savage Laboratories
More about Brexin LA (chlorpheniramine / pseudoephedrine)
- Side Effects
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.